An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Apyx Medical (NASDAQ:APYX) will release its first quarter fiscal year 2024 financial results on May 9, 2024. A conference call will be held to discuss the results and host a question and answer session.
Apyx Medical (NASDAQ:APYX) pubblicherà i risultati finanziari del primo trimestre dell'anno fiscale 2024 il 9 maggio 2024. Si terrà una teleconferenza per discutere i risultati e ospitare una sessione di domande e risposte.
Apyx Medical (NASDAQ:APYX) lanzará sus resultados financieros del primer trimestre del año fiscal 2024 el 9 de mayo de 2024. Se realizará una llamada de conferencia para discutir los resultados y hospedar una sesión de preguntas y respuestas.
Apyx Medical (NASDAQ:APYX)은 2024년 5월 9일 2024 회계연도 첫 분기 재무 결과를 발표할 예정입니다. 결과를 논의하고 질문응답 세션을 주최할 회의 전화가 개최될 예정입니다.
Apyx Medical (NASDAQ:APYX) publiera ses résultats financiers du premier trimestre de l'exercice 2024 le 9 mai 2024. Une conférence téléphonique sera organisée pour discuter des résultats et accueillir une session de questions-réponses.
Apyx Medical (NASDAQ:APYX) wird am 9. Mai 2024 die Finanzergebnisse des ersten Quartals des Geschäftsjahres 2024 veröffentlichen. Ein Konferenzanruf wird abgehalten, um die Ergebnisse zu diskutieren und eine Frage-und-Antwort-Runde zu veranstalten.
Positive
None.
Negative
None.
CLEARWATER, Fla.--(BUSINESS WIRE)--
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that financial results for the first quarter of fiscal year 2024 will be released before the market opens on Thursday, May 9th.
Management will host a conference call at 8:00 a.m. Eastern Time on May 9th to discuss the results of the quarter, and to host a question and answer session. To listen to the call by phone, interested parties may dial 888-645-4404 (or 862-298-0702 for international callers) and provide access code 13745889. Participants should ask for the Apyx Medical Corporation Call. A live webcast of the call will be accessible via the Investor Relations section of the Company’s website and via the following link: Apyx Medical Earnings Webcast
A telephonic replay will be available approximately three hours after the call ends through the following two weeks. The replay can be accessed by dialing 877-660-6853 for U.S. callers or 201-612-7415 for international callers and using the replay access code: 13745889. The webcast will be archived on the Investor Relations section of the Company’s website.
About Apyx Medical Corporation:
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Technology products marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The effectiveness of Renuvion and J-Plasma are supported by more than 90 clinical documents. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.
When will Apyx Medical release its first quarter fiscal year 2024 financial results?
Apyx Medical will release its first quarter fiscal year 2024 financial results on May 9, 2024.
What is the ticker symbol for Apyx Medical ?
The ticker symbol for Apyx Medical is APYX.
How can interested parties listen to the conference call discussing the financial results?
Interested parties can listen to the conference call by dialing 888-645-4404 (or 862-298-0702 for international callers) and providing access code 13745889.
Where can a live webcast of the conference call be accessed?
A live webcast of the conference call can be accessed via the Investor Relations section of the Company's website or through the provided link: Apyx Medical Earnings Webcast.
How long will the telephonic replay be available after the conference call?
The telephonic replay will be available approximately three hours after the call ends and for the following two weeks.
apyx medical corporation, a energy technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. it operates in two segments, advanced energy and original equipment manufacturing (oem). the company develops j-plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. it markets and sells helium plasma technology under the renuvion brand name in the cosmetic surgery market and under the j-plasma brand name in the hospital surgical market. the company's renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue; and the j-plasma system allows surgeons to operate in eliminating unintended tissue trauma. it also designs, develops, manufactures, and sells electrosurgical and oem generators and related accessories for medical device manufacturers. the company was formerly known as bovie medical corporation and changed
